A Randomised, Double Blind Trial Comparing Arimidex Alone With Nolvadex Alone With Arimidex and Nolvadex in Combination, as Adjuvant Treatment in Post-Menopausal Women With Breast Cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Anastrozole (Primary) ; Tamoxifen
- Indications Breast cancer; Early breast cancer
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms ATAC
- Sponsors AstraZeneca
- 31 May 2020 Results (n=818, TransATAC patients)analysing the prognostic value of StemPrintER Risk Score (SPRS) in the TransATAC cohort of post-menopausal ER+/HER2- BC patients, and compare the prognostic information provided by SPRS and OncotypeDX Recurrence Score (RS) for 10-year risk of distant metastasis (DM), presented at the 56th Annual Meeting of the American Society of Clinical Oncology.
- 14 Dec 2019 Results evaluating correlation between and molecular drivers of oncotype DX, prosigna, EndoPredict and breast cancer index in TransATAC tumour sample set, presented at the 42nd Annual San Antonio Breast Cancer Symposium.
- 05 Jun 2012 Actual end date (1 Apr 2010) added as reported by ClinicalTrials.gov.(NCT00849030).